Get the GWPH Research Report and
Also Receive Our Top Trades for 2016!

GW Pharmaceuticals Plc

The company announced the appointment of Scott Giacobello as Chief Financial Officer on March 6th 2017. Scott Giacobello brings 25 years of finance and operational experience to GW Pharmaceuticals. He is an accomplished executive who most recently and until its acquisition by Allergan, Inc. in late 2016, served as Chief Financial Officer for Chase Pharmaceuticals Corporation, a clinical stage biopharmaceutical company focused on the development and commercialization of improved treatments for ne … (See Research Report)
Download Research Report
on GWPH Now